Atopic Dermatitis

Dermira‘s Lebrikizumab Receives the US FDA’s Fast Track Designation to Treat Atopic Dermatitis

Shots:                                                                                                               The US FDA has granted Dermia’s Lebrikizumab Fast Track Designation an investigational drug targeted to treat moderate-to-severe atopic dermatitis The Fast [Read More...]